Evidence map›Paper›PMID 30909497›Full record

ArticleCells2019

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.

Kai Härkönen, Sanna Oikari, Heikki Kyykallio, Janne Capra, Sini Hakkola, Kirsi Ketola, Uma Thanigai Arasu, George Daaboul, Andrew Malloy, Carla Oliveira and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Emerging Advances of Detection Strategies for Tumor-Derived Exosomes.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Kai HärkönenInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. kai.harkonen@uef.fi.
Sanna OikariInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. sanna.oikari@uef.fi.
Heikki KyykallioInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. heikkiky@student.uef.fi.
Janne CapraInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. janne.capra@uef.fi.
Sini HakkolaInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. sinihak@uef.fi.
Kirsi KetolaInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. kirsi.ketola@uef.fi.
Uma Thanigai ArasuInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. uma.thanigai@uef.fi.
George DaaboulNanoview Nanosciences, Boston, MA 02135, USA. gdaaboul@nanoviewbio.com.
Andrew MalloyNanoview Nanosciences, Boston, MA 02135, USA. amalloy@nanoviewdx.com.
Carla OliveiraInstituto de Investigação e Inovação em Saúde, University of Porto, 4099-135 Porto, Portugal. carlaol@ipatimup.pt.
Otto JokelainenInstitute of Clinical Medicine, Clinical Pathology and Forensic Medicine, University of Eastern Finland, 70211 Kuopio, Finland. otto.jokelainen@kuh.fi.
Reijo SironenInstitute of Clinical Medicine, Clinical Pathology and Forensic Medicine, University of Eastern Finland, 70211 Kuopio, Finland. reijo.sironen@kuh.fi.
Jaana M HartikainenInstitute of Clinical Medicine, Clinical Pathology and Forensic Medicine, University of Eastern Finland, 70211 Kuopio, Finland. jaana.hartikainen@uef.fi.
Kirsi RillaInstitute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland. kirsi.rilla@uef.fi.
University of Eastern Finland · FIPrecision BioSciences (United States) · USUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD44 is a multifunctional adhesion molecule typically upregulated in malignant, inflamed and injured tissues. Due to its ability to bind multiple ligands present in the tumor microenvironment, it promotes multiple cellular functions related to tumorigenesis. Recent data has shown that CD44 and its principal ligand hyaluronan (HA) are carried by extracellular vesicles (EV) derived from stem and tumor cells, but the role of CD44 in EV shedding has not been studied so far. To answer this question, we utilized CD44-negative human gastric carcinoma cell line MKN74 manipulated to stably express CD44 standard form (

Indexed as

AnimalsCarcinogenesisCell Line, TumorCell ProliferationCell ShapeChickensChorioallantoic MembraneCollagenExtracellular VesiclesHumansHyaluronan ReceptorsHyaluronic AcidNeoplasm InvasivenessPseudopodiaStomach NeoplasmsCD44 protein, humanCollagenHyaluronan ReceptorsHyaluronic AcidCD44extracellular vesiclegastric cancerhyaluronan

Identifiers

PMID30909497
PMCPMC6468717
OpenAlexW2923802682

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.